Concentrations of circulating gelatinases (Matrix metalloproteinase-2 and-9) are dependent on the conditions of blood collection

被引：35

作者：

Meisser, A ^{[1
]}

Cohen, M ^{[1
]}

Bischof, P ^{[1
]}

机构：

[1] Univ Geneva, Dept Obstet & Gynaecol, Geneva, Switzerland

来源：

CLINICAL CHEMISTRY | 2005年 / 51卷 / 01期

关键词：

D O I：

10.1373/clinchem.2004.041707

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

引用

页码：274 / 276

页数：3

共 8 条

[1]

Hayasaka A, 1996, HEPATOLOGY, V24, P1058

[2]

Jung K, 1998, CLIN CHEM, V44, P1060

[3] Blood specimen collection methods influence the concentration and the diagnostic validity of matrix metalloproteinase 9 in blood [J].

Jung, K ;

Lein, M ;

Laube, C ;

Lichtinghagen, R .

CLINICA CHIMICA ACTA, 2001, 314 (1-2) :241-244

[4] Use of citrate to minimize neutrophil matrix metalloproteinase-9 in human plasma [J].

Makowski, GS ;

Ramsby, ML .

ANALYTICAL BIOCHEMISTRY, 2003, 322 (02) :283-286

[5] Effect of anticoagulants and cell separation media as preanalytical determinants on zymographic analysis of plasma matrix metalloproteinases [J].

Mannello, F ;

Luchetti, F ;

Canonico, B ;

Papa, S .

CLINICAL CHEMISTRY, 2003, 49 (11) :1956-1957

[6]

MARTELLI M, 1993, J REPROD FERTIL, V98, P67

[7] Effects of tumour necrosis factor-α, interleukin-1 α, macrophage colony stimulating factor and transforming growth factor β on trophoblastic matrix metalloproteinases [J].

Meissner, A ;

Chardonnens, D ;

Campana, A ;

Bischof, P .

MOLECULAR HUMAN REPRODUCTION, 1999, 5 (03) :252-260

[8]

Riedel F, 2000, ANTICANCER RES, V20, P3045

← 1 →